These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9383899)

  • 21. Problems in the standardization of allergenic extracts in the U.S.
    Baer H
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1988; (82):9-13. PubMed ID: 3196020
    [No Abstract]   [Full Text] [Related]  

  • 22. Role of proteases on the stability of allergenic extracts.
    Esch RE
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1992; (85):171-7; discussion 177-9. PubMed ID: 1540289
    [No Abstract]   [Full Text] [Related]  

  • 23. Regulation and control of allergenic extracts in the U.S.
    Baer H
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1992; (85):95-100. PubMed ID: 1540302
    [No Abstract]   [Full Text] [Related]  

  • 24. Collaborative study for the establishment of a European Pharmacopoeia Biological Reference Preparation for pertussis toxin--Part 1.
    Dobbelaer R; Daas A; Esposito-Farese ME
    Pharmeuropa Spec Issue Biol; 2001 Aug; 2001(1):15-23. PubMed ID: 11705098
    [No Abstract]   [Full Text] [Related]  

  • 25. [Glycine determination according to the European Pharmacopoeia].
    Peinhardt G
    Pharmazie; 2004 Jan; 59(1):73-4. PubMed ID: 14964427
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Allergenic products standardization--the role of major allergens.
    Helm RM; Burks AW
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1997; (91):164-73. PubMed ID: 9383906
    [No Abstract]   [Full Text] [Related]  

  • 27. [Substances of reference in the European Pharmacopoeia].
    Pharm Acta Helv; 1978; 53(5):136-8. PubMed ID: 724725
    [No Abstract]   [Full Text] [Related]  

  • 28. Combined vaccines: policy and practice in the European Pharmacopoeia.
    Castle P
    Biologicals; 1994 Dec; 22(4):381-7. PubMed ID: 7779365
    [No Abstract]   [Full Text] [Related]  

  • 29. Potency determination of allergenic extracts using mediator release of rat basophil leukemia cells.
    Hoffmann A; Vogel L; Scheurer S; Vieths S; Haustein D
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1997; (91):203-8. PubMed ID: 9383911
    [No Abstract]   [Full Text] [Related]  

  • 30. Properties of colour reference solutions of the European Pharmacopoea in CIE L*a*b* colour space.
    Subert J; Farsa O; Gajdosová Z
    Pharmazie; 2006 Dec; 61(12):1047-8. PubMed ID: 17283667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Collaborative study for the establishment of a European Pharmacopoeia Biological Reference Preparation for serological potency testing of tetanus vaccines for human use: Clostridium tetani guinea pig antiserum (human).
    Hendriksen C; van der Gun J; Winsnes R; Urdal T; Rautmann G; Esposito-Farese ME
    Pharmeuropa Spec Issue Biol; 2001 Aug; 2001(1):7-11. PubMed ID: 11705101
    [No Abstract]   [Full Text] [Related]  

  • 32. Hormones: the role of the European Pharmacopoeia.
    Charton E
    Dev Biol Stand; 1999; 101():159-67. PubMed ID: 10566789
    [No Abstract]   [Full Text] [Related]  

  • 33. Regulatory control and standardization of allergenic extracts. Foreword.
    Vieths S; Löwer J
    Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess; 2009; 96():1-2. PubMed ID: 20799439
    [No Abstract]   [Full Text] [Related]  

  • 34. Establishment of the European Pharmacopoeia Biological Reference Preparation (Ph. Eur. BRP) for hepatitis A vaccine type B (Aventis Pasteur) batch 2.
    Buchheit KH; Daas A
    Pharmeuropa Spec Issue Biol; 2002 Jun; 2002(1):95-108. PubMed ID: 12448033
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Calibration of replacement international standard and European Pharmacopoeia Biological Reference Preparation for Diphtheria Toxoid, Adsorbed.
    Sesardic D; Winsnes R; Rigsby P; Gaines-Das R
    Biologicals; 2001 Jun; 29(2):107-22. PubMed ID: 11580215
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Collaborative study for the establishment of two European Pharmacopoeia Biological Reference Preparations for serological potency testing of tetanus vaccines for veterinary use.
    Lensing HH; Behr-Gross ME; Daas A; Spieser JM
    Dev Biol (Basel); 2002; 111():69-76. PubMed ID: 12678226
    [TBL] [Abstract][Full Text] [Related]  

  • 37. International specification setting--EP perspectives. European Pharmacopoeia.
    Calam DH
    Dev Biol (Basel); 2002; 107():129-34. PubMed ID: 12079187
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [European pharmacopoeia. Recommendation of the advisory meeting of the European council].
    Pharmakotherapia; 1964; 2(1):229-31. PubMed ID: 5876249
    [No Abstract]   [Full Text] [Related]  

  • 39. French application of the European guidelines for regulation of allergenic extracts.
    de Blay F; Doyen V; Bloch-Morot E; Caillot D; Gayraud J; de Laval A; Thillay A;
    J Allergy Clin Immunol; 2013 May; 131(5):1435-7.e7. PubMed ID: 23375207
    [No Abstract]   [Full Text] [Related]  

  • 40. Elaborating European Pharmacopoeia monographs for biotherapeutic proteins using substances from a single source.
    Buda M; Wicks S; Charton E
    Pharmeur Bio Sci Notes; 2016; 2016():129-134. PubMed ID: 28279254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.